(Q34973860)

5 August 2017

title

The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects (English)

1 reference

5 August 2017

Amit N Keswani

1

1 reference

5 August 2017

Kelly J Peyton

2

1 reference

5 August 2017

William Durante

3

1 reference

5 August 2017

Andrew I Schafer

4

1 reference

5 August 2017

David A Tulis

5

1 reference

5 August 2017

publication date

2 April 2009

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

5 August 2017

published in

1 reference

5 August 2017

volume

14

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

116-124

1 reference

Novel therapies for cyclic GMP control of vascular smooth muscle growth

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Histological and morphometric analyses for rat carotid balloon injury model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Rat carotid artery balloon injury model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Salutary properties of YC-1 in the cardiovascular and hematological systems

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

YC-1, a novel activator of platelet guanylate cyclase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation

8 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

YC-1 attenuates homotypic human neutrophil aggregation through inhibition of phosphodiesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333266

YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2702762

Phosphodiesterase type 5 inhibition enhances vasorelaxation caused by nitroprusside in guinea pig intact heart and isolated aorta

26 October 2018

1 reference

12 December 2020

YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation

1 reference

12 December 2020

Regional differentiation in rat aorta: L-arginine metabolism and cGMP content in vitro

1 reference

12 December 2020

In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery

1 reference

12 December 2020

Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury

1 reference

12 December 2020

Identifiers

DOI

10.1177/1074248409333266

1 reference

5 August 2017

1 reference

5 August 2017

1 reference